Yiduo Zhang

Yiduo Zhang

Auto-generated profile, based on publicly available information

Yiduo Zhang

Department of Laboratory Medicine, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 August 2022 in Journal of Clinical Laboratory Analysis
Verified
Journal Article
Open access
YZYiduo Zhang
Yiduo Zhang
XHXiaocui Huang
Xiaocui Huang
CLChao Li
Chao Li
JZJing Zhang
Jing Zhang
XYXingnan Yu
Xingnan Yu
FYFan Yu
Fan Yu
Background: Bone turnover markers (BTMs) have been studied for application in clinical medicine. However, BTMs in children are challenging, and few studies explore these BTMs in children. The application of BTMs is complicated mainly due to pre‐analytical factors, variable reference intervals of age‐ and sex‐related BTMs for adolescents and children in different regions and laboratories. Therefore, laboratory testing of BTMs is critical for understanding pediatric bone development and metabolism, which provides additional information about bone development and diseases.Methods: Literature search was conducted using the MeSH term “child” combined with the terms that bone turnover markers such as “osteocalcin,” “Procollagen type I N‐terminal propeptide,” “procollagen type I C‐terminal propeptide,” “osteocalcin,” “N‐terminal cross‐linked telopeptide,” and “C‐terminal cross‐linked telopeptide,” Several databases including Web of Science, Google Scholar, and PubMed were searched to obtain the relevant studies.Results: BTMs represent the combined effects of skeletal development, growth, and remodeling in children, which can be used in clinical pediatrics to assist in the diagnosis and prognosis of bone metabolic disorders.Conclusion: BTMs are clearly helpful for diagnosis and monitoring of bone growth and development as well as bone metabolic disorders.

28 July 2023 in International Journal Of Clinical Practice
Verified
Journal Article
Open access
PDF file
YZYiduo Zhang
Yiduo Zhang
JZJing Zhang
Jing Zhang
XHXiaocui Huang
Xiaocui Huang
XYXingnan Yu
Xingnan Yu
YLYe Li
Ye Li
WZWenjie Zhou
Wenjie Zhou
Objectives. To determine the bone metabolic marker changes from childhood to adolescence and to provide reference values for monitoring bone development in children in Southwest China. Methods. We surveyed 703 participants attending physical examinations from April 2019 and August 2021. Twenty-eight participants were excluded for lack of laboratory tests, and 14 people were excluded for diseases that might affect bone metabolism. A total of 661 children were selected for the study. According to the main developmental periods, the children were divided into preschool, preadolescence, and adolescence groups. Serum bone turnover markers including β-isomerized C-terminal telopeptide of type I collagen (β-CTx), N-terminal midfragment of osteocalcin (N-MID), and procollagen type 1 N-propeptide (P1NP) as well as growth and development indices such as serum calcium (Ca), phosphorus (Pi), alkaline phosphatase (ALP), and vitamin D were measured. The changes in bone metabolism-related markers and the correlations between the indices were analyzed. Results. During the development in boys, the levels of β-CTx and N-MID increased with age from preschool to adolescence, while the levels of P1NP decreased and then increased. In girls, the levels of β-CTx and N-MID plateaued in early adolescence and showed little change in subsequent adolescence, while the levels of P1NP exhibited a downward trend. The correlations between bone metabolism markers and vitamin D were not significant. Conclusions. The levels of bone metabolism markers differed between boys and girls. Reference intervals can be used as essential tools to examine the levels of bone metabolism markers reasonably.

16 August 2022 in Journal of Clinical Laboratory Analysis
Verified
Journal Article
Open access
HLHai Liu
Hai Liu
QLQing Li
Qing Li
YZYiduo Zhang
Yiduo Zhang
DHDongyue Huang
Dongyue Huang
FYFan Yu
Fan Yu
Objective: To evaluate the consistency between the results of Sysmex UF‐5000 system and Atellica® UAS 800 Urine Sediment Analyzer.Methods: A total of 636 random urine samples were collected from inpatients and outpatients from March to September 2021. Urine was collected for analysis by the Sysmex UF‐5000, Atellica UAS 800 systems, and manual microscopic examination. The results of manual microscopy as the gold standard, the coincidence rate and false‐negative rate of Sysmex UF‐5000 and Atellica UAS 800 systems in the detection of red blood cells, white blood cells, and casts were calculated.Results: The coincidence rates of red blood cells, white blood cells, and cast, crystals, and other sediment components for the Sysmex UF‐5000 system were 85.37%, 87.89%, 91.67%, 88.36%, and 71.86%. The false‐negative rates were 28.47%, 3.75%, 68.97%, 37.25%, and 30.63%. The coincidence rates of red blood cells, white blood cells, and cast, crystals, and other sediment components for the Atellica UAS 800 system were 85.06%, 90.25%, 59.12%, 91.67%, and 67.45% and the false‐negative rates were 60.42%, 21.25%, 36.21%, 19.64%, and 35.80%.Conclusion: Two instruments are superior in the detection of red blood cells and white blood cells. The Atellica UAS 800 system with image review has a good coincidence rate in the identification of crystals and casts. The identification of various sediment components in urine by both instruments meets the laboratory requirements. Two instruments with different methodologies have their own characteristics, and we should reasonably use them according to the conditions of the laboratory.

16 December 2023 in International Journal Of Clinical Practice
Verified
Journal Article
Open access
PDF file
YZYiduo Zhang
Yiduo Zhang
RLRuiying Li
Ruiying Li
JZJing Zhang
Jing Zhang
WZWenjie Zhou
Wenjie Zhou
FYFan Yu
Fan Yu
Background. Changes in bone metabolism during pregnancy have not received sufficient attention because of the lack of effective screening tools. Bone turnover markers (BTMs) could reflect the changes of bone metabolism. Currently, reference intervals for bone metabolism during normal pregnancy are inconclusive. This study aimed to determine reference intervals for BTMs in pregnant women taking prenatal care and to facilitate clinical research on diseases affecting bone metabolism during pregnancy. Methods. We surveyed 120 low-risk pregnant women attending routine antenatal care from January 2020 to March 2020. The serum levels of procollagen type I N-propeptide (PINP), N-terminal osteocalcin (N-MID), and C-terminal telopeptide of type I collagen (β-CTX) were measured in the first trimester (28 weeks). Reference intervals for BTMs during pregnancy were analyzed. The Kruskal–Wallis test and paired t-test are used to analyze differences between groups. Spearman correlation coefficients expressed the measure of linear association. Results. The bone resorption marker β-CTX in third trimester increases compared to the first trimester and the second trimester ( < 0.001, < 0.001). The bone formation markers PINP and N-MID were decreased from the first trimester to the second trimester ( = 0.01, < 0.001) and then raised from the second trimester to the third trimester ( < 0.001, < 0.001). Two indices of bone turnover rate, β-CTX/PINP and β-CTX/N-MID, were increased from the first trimester to the second trimester ( < 0.001, < 0.001) and then decreased from the second trimester to the third trimester ( = 0.02, < 0.001). Conclusion. This study established reference intervals for BTMs in pregnant women and observed the changes in BTMs during the different trimesters of pregnancy. The present findings can help in clinical monitoring of the effects of pregnancy diseases on the bone metabolism of pregnant women.

28 April 2023 in International Journal Of Clinical Practice
Verified
Journal Article
Open access
PDF file
JZJing Zhang
Jing Zhang
WZWen-Jie Zhou
Wen-Jie Zhou
YZYi-Duo Zhang
Yi-Duo Zhang
CLChuan-Jiao Liu
Chuan-Jiao Liu
FYFan Yu
Fan Yu
YJYong-Mei Jiang
Yong-Mei Jiang
Background. This study aimed to determine the effect of body mass index (BMI) on bone turnover markers in girls with idiopathic central precocious puberty (ICPP) according to weight status at diagnosis. Methods. Two hundred and eleven girls with ICPP were divided according to their weight status at diagnosis into three groups: normal weight, overweight, and obese. The serum levels of total procollagen type 1 N-terminal propeptide (P1NP), N-terminal midfragment of osteocalcin, β-C-terminal telopeptide of type 1 collagen, and some biochemical indicators were measured. Associations between variables were evaluated by multiple regression analysis. Results. Serum P1NP concentrations were significantly different among groups ( ). No other significant differences were noted in N-terminal midfragment of osteocalcin and β-C-terminal telopeptide of type 1 collagen. BMI was associated with estradiol (r = 0.155, ) and inversely associated with P1NP (r = −0.251, ), luteinizing hormone peak (r = −0.334, ), follicle-stimulating hormone peak (r = −0.215, ), and luteinizing hormone/follicle-stimulating hormone peak (r = −0.284, ). Multiple regression analysis of factors associated with BMI showed that it was correlated with P1NP, follicle-stimulating hormone base, and luteinizing hormone peak in the overweight group and the obese group. Conclusions. Our findings showed that BMI was associated with P1NP, revealing the reduction of bone formation in overweight and obese girls with ICPP. During the diagnosis and treatment of girls with ICPP, attention should be paid to body weight and bone metabolism.

27 March 2024 in Sexual Medicine
Verified
Journal Article
Open access
PDF file
CLChuanjiao Liu
Chuanjiao Liu
YZYiduo Zhang
Yiduo Zhang
QXQian Xu
Qian Xu
CYChen Yang
Chen Yang
YTYuanting Tang
Yuanting Tang
FYFan Yu
Fan Yu
Recurrent pregnancy loss (RPL) is a severe traumatic event for women of childbearing age. However, the association between RPL and female sexual dysfunction was unknown. The study sought to investigate the association between RPL and sexual dysfunction, and to explore the risk factors of sexual dysfunction for RPL patients. A multicenter cross-sectional study involving both RPL patients and healthy women was performed in 3 different hospitals in West China from May 2021 to January 2023. Baseline information including sociodemographic data and disease histories were collected. The Female Sexual Function Index (FSFI) was used to assess the sexual function of participants. The main outcome was the proportion of women at increased risk of sexual dysfunction (total FSFI scores 24 kg/m2 (adjusted odds ratio [OR], 4.132; 95% confidence interval [CI], 1.902-8.976, P < .001), working >8 h/d (adjusted OR, 2.111; 95% CI, 1.020-4.369, P = .044), and unexplained RPL (adjusted OR, 3.785; 95% CI, 1.967-7.280, P < .001) were independent risk factors of sexual dysfunction for RPL patients. RPL patients, especially those patients with the previously mentioned risk factors, should be focused on the risk of sexual dysfunction, and appropriate preventions could be applied. We explored the association between RPL and sexual dysfunction and explored the risk factors of sexual dysfunction among RPL patients for the first time, and the multicenter data increased the generalizability of results. However, the cross-sectional design did not provide an exact causal relationship between RPL and sexual dysfunction, and potential risk factors related to mental health were not investigated. RPL patients were at an increased risk of sexual dysfunction. Overweight, fatigue caused by work, and unexplained RPL were risk factors of sexual dysfunction for RPL patients.